Top Markets
Coin of the day
Hubei Biocause Pharmaceutical Co., Ltd. Hubei Biocause Pharmaceutical Co., Ltd.

Hubei Biocause Pharmaceutical Co., Ltd.

000627
Rang in aandelen #9082
Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a... Hubei Biocause Pharmaceutical Co., Ltd., based in Jingmen, China, operates a multifaceted business. Its primary activities within China involve the provision of life and motor insurance policies. Additionally, the company is engaged in the pharmaceutical, chemical, and new energy fuel industries. Specifically, in the pharmaceutical field, it conducts contract research, development, and manufacturing of active pharmaceutical ingredients (APIs), intermediate compounds, and various drug forms such as tablets, granules, and capsules. Its chemical offerings include substances like dimethyl ether gas and a-chloropropionyl chloride. The firm also boasts an international presence, distributing its products to markets including the United States, the European Union, and other global locations.
Aandeelprijs
$0.2219522
Laatst gesynchroniseerd: 2025-09-11
Marktkapitalisatie
$1.10B
Verandering (1 dag)
0.04%
Verandering (1 jaar)
0.17%
Land
CN
Handel Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Aandelsplitsingen voor Hubei Biocause Pharmaceutical Co., Ltd. (000627)
Het aandeel Hubei Biocause Pharmaceutical Co., Ltd. (symbool: 000627) heeft in totaal 8 splitsingen ondergaan.
De meest recente splitsing vond plaats op Apr 12, 2010.
Eén aandeel 000627 dat vóór Dec 27, 1996 werd gekocht, staat nu gelijk aan 21.70959235632 aandelen 000627.
Lijst van aandelen splitsingen
Jaar Splitsing Vermenigvuldiging Cumulatieve vermenigvuldiging
2010-04-12 37:20 x1.85 x21.70959235632
2005-11-09 33:25 x1.32 x11.7349147872
2002-06-12 23:20 x1.15 x8.89008696
2001-09-24 3:2 x1.5 x7.7305104
2001-05-23 59649:50000 x1.19298 x5.1536736
2000-05-16 6:5 x1.2 x4.32
1999-09-07 9:5 x1.8 x3.6
1996-12-27 2:1 x2 x2
Aandelsplitsingen van vergelijkbare bedrijven of concurrenten